Corbus Pharmaceuticals Hldgs Inc (CRBP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Sales | 0 | 0 | 0 | 882 | 3,937 |
| Gross Profit | N/A | N/A | N/A | 882 | 3,937 |
| Operating Expenses | 48,721 | 45,078 | 39,836 | 56,871 | 126,748 |
| Operating Income | -48,721 | -45,078 | -39,836 | -55,989 | -122,810 |
| Interest Expense | 1,872 | 3,858 | 2,132 | 1,831 | 1,028 |
| Other Income | 10,384 | 4,332 | -379 | 12,179 | 12,569 |
| Pre-tax Income | -40,209 | -44,604 | -42,347 | -45,640 | -111,269 |
| Net Income Continuous | -40,209 | -44,604 | -42,347 | -45,640 | -111,269 |
| Net Income | $-40,209 | $-44,604 | $-42,347 | $-45,640 | $-111,269 |
| EPS Basic Total Ops | -3.68 | -10.31 | -10.15 | -11.15 | -42.64 |
| EPS Basic Continuous Ops | -3.68 | -10.31 | -10.15 | -11.15 | -42.77 |
| EPS Diluted Total Ops | -3.68 | -10.31 | -10.15 | -11.15 | -42.64 |
| EPS Diluted Continuous Ops | -3.68 | -10.31 | -10.15 | -11.15 | -42.77 |
| EPS Diluted Before Non-Recurring Items | -3.68 | -10.31 | -8.95 | -11.11 | -42.64 |
| EBITDA(a) | $-51,064 | $-44,119 | $-38,205 | $-52,951 | $-120,825 |